Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $17.4 million.

  • Xtant Medical Holdings' Non-Current Debt fell 906.05% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year decrease of 906.05%. This contributed to the annual value of $22.0 million for FY2024, which is 2837.42% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Non-Current Debt stood at $17.4 million for Q3 2025, which was down 906.05% from $22.3 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Non-Current Debt registered a high of $22.3 million during Q2 2025, and its lowest value of $9.7 million during Q4 2022.
  • For the 5-year period, Xtant Medical Holdings' Non-Current Debt averaged around $15.6 million, with its median value being $15.4 million (2023).
  • Per our database at Business Quant, Xtant Medical Holdings' Non-Current Debt plummeted by 8533.41% in 2021 and then surged by 7721.69% in 2023.
  • Over the past 5 years, Xtant Medical Holdings' Non-Current Debt (Quarter) stood at $11.8 million in 2021, then decreased by 17.82% to $9.7 million in 2022, then soared by 77.22% to $17.2 million in 2023, then increased by 28.37% to $22.0 million in 2024, then fell by 21.03% to $17.4 million in 2025.
  • Its last three reported values are $17.4 million in Q3 2025, $22.3 million for Q2 2025, and $22.2 million during Q1 2025.